Advertisement

Topics

J&J shares lose ground on fears of Pfizer's answer to Remicade

09:36 EDT 18 Oct 2016 | Yahoo News

Logo of healthcare company Johnson & Johnson is seen in Zug(Reuters) - Booming pharmaceutical sales drove strong quarterly results for Johnson & Johnson , but the company's shares fell more than 2 percent on worries that its blockbuster Remicade arthritis drug would soon face cheaper competition.


Original Article: J&J shares lose ground on fears of Pfizer's answer to Remicade

NEXT ARTICLE

More From BioPortfolio on "J&J shares lose ground on fears of Pfizer's answer to Remicade"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...